Paediatric Biopharmaceutics Flashcards

1
Q

What are the physiological changes that occur in children that can alter absorption and pharmacokinetics?

A
  • saliva production
  • gastric pH and emptying rate
  • intestinal transit, SA and motility
  • drug metabolising enzymes
  • drug efflux transporters
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What can reduced acid secretion in neonates do?

A

Increase bioavailability of acid labile drugs

  • increase gastric solubility of acidic drugs
  • decrease solubility of basic drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What can impact the amount of liquid a patient is likely to take?

A

saliva flow and stomach volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the general trend of pH along GIT as you get older?

A

pH decreases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What effect does transit time have on paediatric formulations?

A

Irregular intestinal motility leads to variable transit times which can be a problem for controlled release formulations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What happens to permeability as you age?

A

Decreases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How is metabolism affected in paediatric patients?

A

Children have a larger liver size and hepatic blood flow per body weight so there is more 1st pass metabolism and increased clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is formulation bridging?

A

Assessing the rate and extent of absorption from one formulation vs. another

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is relative bioavailability?

A

Comparing Cmax and AUC between 2 products

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is bioequivalence?

A

Assessment of statistical equivalence of Cmax and AUC from 2 different products using confidence intervals and approach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is formulation bridging necessary?

A
  • Allows you to select an appropriate dose

- Allows you to make adjustments for children with chronic conditions who’s treatment may be life long

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is a relative bioavailability study?

A

A study done on healthy adult volunteers - comparison between adult and paediatric formulations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why can paediatric formulations be a problem?

A

Most pharmacokinetic data available is for adults and children have physiological differences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What can in silico physiology based pharmacokinetics modelling be used for?

A

To predict formulation performance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the typical approach for in silico PBPK?

A

Develop and validate a model based on adult data then alter physiological parameters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How can food alter formulation performance and drug absorption?

A
  • Altered composition of GI fluid
  • Different gastric emptying rates
  • Altered blood flow
  • Drug binding to food (affects PK)
17
Q

What effect can mixing food and medicines have?

A
  • Can affect pH dependent release
  • Dissolution / release rate
  • Stability of API